| |
|
|
| Name: |
Vestal Point Capital LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10012 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
11 |
|
View All Holdings |
Currently
Viewing:
Decreased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
NBIX |
Neurocrine Biosciences Inc |
3 |
- |
$136.66 |
$97,923,000 |
710,000 |
8.1% |
-7,485,000 |
-90,000 |
0.76 |
Biotechnology |
|
|
ASND |
Ascendis Pharma AS |
4 |
- |
$137.45 |
$79,364,000 |
525,000 |
6.56% |
645,000 |
-100,000 |
0.812 |
N/A |
|
|
SLNO |
Soleno Therapeutics Inc |
6 |
- |
$0.16 |
$53,500,000 |
1,250,000 |
4.42% |
1,175,000 |
-50,000 |
1.57 |
N/A |
|
|
INSM |
Insmed Inc |
15 |
- |
$56.98 |
$20,348,000 |
750,000 |
1.68% |
-7,543,000 |
-150,000 |
0.495 |
Biotechnology |
|
|
IMTX |
Immatics N.V |
27 |
- |
$11.28 |
$12,612,000 |
1,200,000 |
1.04% |
-9,501,000 |
-900,000 |
1.907 |
N/A |
|
|
FULC |
Fulcrum Therapeutics, Inc. |
37 |
- |
$0.00 |
$6,561,000 |
695,000 |
0.54% |
-358,000 |
-330,000 |
1.103 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
41 |
- |
$3.45 |
$5,872,000 |
800,000 |
0.49% |
1,047,000 |
-490,000 |
0.675 |
Biotechnology |
|
|
LYRA |
Lyra Therapeutics, Inc. |
46 |
- |
$0.00 |
$4,976,000 |
800,000 |
0.41% |
-10,744,000 |
-2,200,000 |
1.522 |
N/A |
|
|
PCRX |
Pacira Pharmaceuticals, Inc. |
52 |
- |
$30.46 |
$2,338,000 |
80,000 |
0.19% |
-38,150,000 |
-1,120,000 |
0.162 |
Drug Manufacturers - ... |
|
|
RPHM |
Reneo Pharmaceuticals, Inc. |
56 |
- |
$1.72 |
$490,000 |
295,375 |
0.04% |
-150,000 |
-104,625 |
0.874 |
N/A |
|
|
AFMD |
Affimed Nv |
57 |
- |
$4.06 |
$292,000 |
55,000 |
0.02% |
-49,000 |
-491,067 |
0.048 |
N/A |
|
